CA2098773A1 - Recombinant Coccidia and Its Use in a Vaccine - Google Patents

Recombinant Coccidia and Its Use in a Vaccine

Info

Publication number
CA2098773A1
CA2098773A1 CA2098773A CA2098773A CA2098773A1 CA 2098773 A1 CA2098773 A1 CA 2098773A1 CA 2098773 A CA2098773 A CA 2098773A CA 2098773 A CA2098773 A CA 2098773A CA 2098773 A1 CA2098773 A1 CA 2098773A1
Authority
CA
Canada
Prior art keywords
coccidia
recombinant
species
vaccine
strains
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2098773A
Other languages
French (fr)
Other versions
CA2098773C (en
Inventor
Eng-Hong Lee
Vern L. Seligy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA002098773A priority Critical patent/CA2098773C/en
Publication of CA2098773A1 publication Critical patent/CA2098773A1/en
Application granted granted Critical
Publication of CA2098773C publication Critical patent/CA2098773C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The present invention provides for recombinant coccidia comprising a relatively non-pathogenic strain of coccidia to which has been introduced DNA from one or more other strains or species of coccidia. In an aspect of the invention, there is provided a recombinant coccidiosis vaccine comprising a relatively non-pathogenic strain of coccidia to which has been introduced sufficient DNA of one or more other strains or species of coccidia to produce immunity to the multiple species in a host through inoculation of the host by the recombinant species.
CA002098773A 1993-06-18 1993-06-18 Recombinant coccidia and its use in a vaccine Expired - Lifetime CA2098773C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002098773A CA2098773C (en) 1993-06-18 1993-06-18 Recombinant coccidia and its use in a vaccine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002098773A CA2098773C (en) 1993-06-18 1993-06-18 Recombinant coccidia and its use in a vaccine

Publications (2)

Publication Number Publication Date
CA2098773A1 true CA2098773A1 (en) 1994-12-19
CA2098773C CA2098773C (en) 1999-09-21

Family

ID=4151815

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002098773A Expired - Lifetime CA2098773C (en) 1993-06-18 1993-06-18 Recombinant coccidia and its use in a vaccine

Country Status (1)

Country Link
CA (1) CA2098773C (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999008704A1 (en) * 1997-08-20 1999-02-25 Lee Eng Hong Method of protecting against chronic infections
US6495146B1 (en) 1995-06-07 2002-12-17 Pfizer Incorporated In ovo vaccination against coccidiosis
US6500438B2 (en) 1995-06-07 2002-12-31 Pfizer Incorporated In ovo vaccination against coccidiosis
US6627205B2 (en) 1997-12-01 2003-09-30 Pfizer Incorporated Ovo vaccination against coccidiosis
US6984378B1 (en) 1999-02-26 2006-01-10 Pfizer, Inc. Method for the purification, recovery, and sporulation of cysts and oocysts
US7166290B2 (en) 2001-08-30 2007-01-23 Embrex, Inc. Methods for producing oocysts
US11000580B2 (en) 2010-12-27 2021-05-11 Eng Hong Lee Roadmap for controlling malaria

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6495146B1 (en) 1995-06-07 2002-12-17 Pfizer Incorporated In ovo vaccination against coccidiosis
US6500438B2 (en) 1995-06-07 2002-12-31 Pfizer Incorporated In ovo vaccination against coccidiosis
US7018640B2 (en) 1995-06-07 2006-03-28 Pfizer Incorporated In ovo vaccination against coccidiosis
WO1999008704A1 (en) * 1997-08-20 1999-02-25 Lee Eng Hong Method of protecting against chronic infections
US6306385B1 (en) 1997-08-20 2001-10-23 Eng-Hong Lee Method of protecting against chronic infections
US6627205B2 (en) 1997-12-01 2003-09-30 Pfizer Incorporated Ovo vaccination against coccidiosis
US6984378B1 (en) 1999-02-26 2006-01-10 Pfizer, Inc. Method for the purification, recovery, and sporulation of cysts and oocysts
US7229615B2 (en) 1999-02-26 2007-06-12 Pfizer, Inc. Method for the purification, recovery, and sporulation of cysts and oocysts
US7166290B2 (en) 2001-08-30 2007-01-23 Embrex, Inc. Methods for producing oocysts
US9107865B2 (en) 2001-08-30 2015-08-18 Zoetis Services Llc Methods for producing oocysts
US11000580B2 (en) 2010-12-27 2021-05-11 Eng Hong Lee Roadmap for controlling malaria

Also Published As

Publication number Publication date
CA2098773C (en) 1999-09-21

Similar Documents

Publication Publication Date Title
BG102784A (en) Synthetic hiv genes
CA2011878A1 (en) Immunogenic regions on the e7 protein of human papillomavirus type 16
AU7154394A (en) Nucleic acid-binding oligomers possessing N-branching for therapy and diagnostics
PL335050A1 (en) Synthetic genes gag hiv
WO1995006732A3 (en) Bacterial exported proteins and acellular vaccines based thereon
CA2195935A1 (en) Streptococcus equi vaccine
AU3904685A (en) Cloning of dna for protozoal antigens
BG105838A (en) A container having pressure responsive panels
CA2165954A1 (en) Prostaglandin receptor fp and dna encoding it
CA2098773A1 (en) Recombinant Coccidia and Its Use in a Vaccine
AU1463097A (en) Helicobacter pylori bacterioferritin
AU7161994A (en) nucleic acid-binding oligomers possessing C-branching for therapy and diagnostics
NZ332912A (en) rinseable hard surface cleaner containing a silicate, a hydrophobic acrylic polymer and a surfactant
WO1999004011A3 (en) Hiv-1 group o antigens and uses thereof
EP1666057A3 (en) An acellular vaccine comprising Bordetella pertussis antigens
WO1994016079A3 (en) Novel bacillus thuringiensis toxins active against corn rootworm larvae
CA2245545A1 (en) Vaccines against varicella zoster virus gene 63 product
AU2833789A (en) Non-reverting rna viruses
EP0806476A3 (en) Attenuated strains of leishmania and uses thereof
WO1995005460A3 (en) Feline immunodeficiency virus isolate ncsu 1
CA2084384A1 (en) Dna coding for uricase and process for producing uricase
AU1099697A (en) Novel xylanases, genes encoding them, and uses thereof
AU8867198A (en) (mycobacterium) strain with modified (erp) gene and vaccine composition containing same
AU4815497A (en) Biocontrol of fungal soilborne pathogens by (pythium oligandrum)
AU8132994A (en) Nucleic acids encoding {his5, trp7, tyr8}-gnrh preprohormone and {ser8}-gnrh preprohormone and their uses

Legal Events

Date Code Title Description
EEER Examination request